)
)
)
Building Effective Strategies for Parallel Life Science Patent Litigation Across International Jurisdictions
Managing parallel patent litigation proceedings across global forums remains an important challenge for the pharmaceutical, biotechnology and broader life sciences sectors. Drawing on recent, high-profile cross-border disputes as case studies, this session explores how litigators are developing effective strategies for coordinating parallel multi-jurisdictional patent disputes, focusing on venue selection, procedural timing, enforcement sequencing, settlement alignment and minimising the risk of conflicting decisions.
- Explore the practical challenges associated with litigating life science patents in parallel across Europe, the U.S., Canada, Latin America and Asia.
- Understand how litigants are approaching key strategic considerations for cross-border disputes, including venue selection, procedural timing, enforcement sequencing, settlement alignment and minimising the risk of conflicting decisions.
- Review recent high-profile multi-jurisdictional litigation cases – including Moderna v. Pfizer/BioNTech, Xtandi, Apixaban, Rivaroxaban, Januvia/Sitagliptin and Revlimid – and assess the key takeaways for your future parallel dispute strategy.
- Assess best practices for coordinating parallel proceedings between in-house and external teams.
